pyridostigmine bromide

Generic: pyridostigmine bromide

Labeler: method pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pyridostigmine bromide
Generic Name pyridostigmine bromide
Labeler method pharmaceuticals, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pyridostigmine bromide 30 mg/1

Manufacturer
Method Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 58657-810
Product ID 58657-810_41b66d64-08b1-bd0c-e063-6394a90a5b86
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211181
Listing Expiration 2026-12-31
Marketing Start 2019-06-01

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 58657810
Hyphenated Format 58657-810

Supplemental Identifiers

RxCUI
903841
UNII
KVI301NA53

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pyridostigmine bromide (source: ndc)
Generic Name pyridostigmine bromide (source: ndc)
Application Number ANDA211181 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 30 mg/1
source: ndc
Packaging
  • 21 TABLET in 1 BOTTLE (58657-810-21)
source: ndc

Packages (1)

58657-810-21 21 TABLET in 1 BOTTLE (58657-810-21)

Ingredients (1)

pyridostigmine bromide (30 mg/1)

Linked Drug Pages (1)

Pyridostigmine Bromide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "41b66d64-08b1-bd0c-e063-6394a90a5b86", "openfda": {"unii": ["KVI301NA53"], "rxcui": ["903841"], "spl_set_id": ["e756717f-941b-42f2-ba3b-03798c005ae7"], "manufacturer_name": ["Method Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "21 TABLET in 1 BOTTLE (58657-810-21)", "package_ndc": "58657-810-21", "marketing_start_date": "20190601"}], "brand_name": "Pyridostigmine Bromide", "product_id": "58657-810_41b66d64-08b1-bd0c-e063-6394a90a5b86", "dosage_form": "TABLET", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "58657-810", "generic_name": "PYRIDOSTIGMINE BROMIDE", "labeler_name": "Method Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "30 mg/1"}], "application_number": "ANDA211181", "marketing_category": "ANDA", "marketing_start_date": "20190601", "listing_expiration_date": "20261231"}